Regenxbio Inc (RGNX)

Net profit margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net income	US$ in thousands	-263,494	-280,321	127,840	-111,250	-94,733
Revenue	US$ in thousands	85,585	89,470	446,639	291,249	59,562
Net profit margin		-307.87%	-313.31%	28.62%	-38.20%	-159.05%

December 31, 2023 calculation

Net profit margin = Net income ÷ Revenue
= $-263,494K ÷ $85,585K
= -307.87%

The net profit margin of Regenxbio Inc has displayed significant fluctuations over the past five years. In 2019, the net profit margin was notably negative at -268.88%, indicating a substantial loss relative to revenue. This was followed by a further decline in profitability in 2020, with the net profit margin plummeting to -71.98%, but still reflecting a significant loss.

However, the company experienced a sharp improvement in profitability in 2021, where the net profit margin surged to 27.18%, signifying a return to profitability and a notable increase in earnings relative to revenue. This positive trend was short-lived, as evident from the subsequent two years.

In 2022 and 2023, Regenxbio Inc faced challenges once again, with the net profit margin turning negative at -248.68% and -291.99% respectively. These figures indicate substantial losses exceeding the company's revenue, highlighting financial difficulties and operational inefficiencies during these periods.

Overall, the fluctuating and predominantly negative net profit margins of Regenxbio Inc suggest a volatile financial performance characterized by periods of profitability alternating with severe losses. It is imperative for the company to address the underlying factors contributing to these fluctuations to ensure sustained profitability and financial stability in the future.